Posted by Admin | 6:07 PM

I had guessed that this sort of thing was going on all the time, but being kept very well hidden.  Now we have some more evidence. An artic...

Labels: conflicts of interest, deception, health care corruption, manipulating clinical research, patient advocacy groups, PhRMA, public relations, suppression of medical research

Posted by Admin | 6:08 AM

Concerns about suppression and manipulation of clinical research to serve vested interests have finally gotten a little more mainstream. B...

Labels: anechoic effect, conflicts of interest, institutional conflicts of interest, manipulating clinical research, research subjects, suppression of medical research

Posted by Admin | 2:03 PM

We have often discussed how health care organizations now seem prone to diversion from their stated missions, often when money is the object...

Labels: Cystic Fibrosis Foundation, disease-specific organizations, executive compensation, guidelines, manipulating clinical research, mission-hostile management, Vertex Pharmaceutical

Posted by Admin | 12:04 PM

There are new, and troubling developments in the long running case of Dan Markingson, the psychiatric patient and research subject who commi...

Labels: accountability, AstraZeneca, atypical anti-psychotics, conflicts of interest, deception, manipulating clinical research, mission-hostile management, research subjects, University of Minnesota

Posted by Admin | 7:57 AM

In 2007, we first discussed the case of the amazing pricing of H P Acthar, a very old drug of questionable usefulness, as an example of the...

Labels: ACTH, deception, executive compensation, health care prices, institutional conflicts of interest, key opinion leaders, manipulating clinical research, marketing, Questcor, suppression of medical research

Posted by Admin | 12:57 PM

On 1BoringOldMan, Mickey, the semi-anonymous retired psychiatrist blogger, has updated the saga of Study 329 .  The manipulation of Study 32...

Labels: GlaxoSmithKline, manipulating clinical research, Martin Keller, Paxil, Study 329

Posted by Admin | 8:55 AM

For over 20 years, clinical practice guidelines (CPGs) have been touted to improve health care quality and control costs.  Enormous numbers ...

Labels: conflicts of interest, guidelines, Institute of Medicine, manipulating clinical research, SSRIs, suppression of medical research, transparency